Journal · Molecular imaging · Updated 22 November 2026
Molecular Imaging and Biology
Read Molecular Imaging and Biology articles on DeepDyve. No university library needed.
Molecular Imaging and Biology covers molecular imaging from the lab to the clinic, with recent papers on PET tracers for bladder cancer, targeted nanoparticles for MRI and CRISPR-based imaging in living cells. It’s an official journal of the World Molecular Imaging Society, the European Society for Molecular Imaging and the Federation of Asian Societies for Molecular Imaging, published by Springer Nature. It was previously published as Clinical Positron Imaging. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.
Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.
Personal plans aren’t for business use. Reading for work? See Enterprise.
Molecular Imaging and Biology at a glance
- Full title
- Molecular Imaging and Biology
- Former title
- Clinical Positron Imaging
- Abbreviation (NLM)
- Mol Imaging Biol
- Publisher
- Springer Nature
- Print ISSN
- 1536-1632
- Online ISSN (eISSN)
- 1860-2002
- Current title since
- 2002
- Subjects
- Diagnostic Imaging, Molecular Biology
- Access model
- Hybrid (41% free to read in 2026)
Ways to access Molecular Imaging and Biology
41% of the articles Molecular Imaging and Biology published from January 1 to November 20, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.
- Open access articles. 41% of Molecular Imaging and Biology articles published from January 1 to November 20, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
- The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
- Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
- NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
- A library. Your university, hospital or public library may subscribe to Molecular Imaging and Biology. Check its journal list and whether it offers remote access.
- DeepDyve. Read Molecular Imaging and Biology articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.
Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.
Impact factor and metrics
Molecular Imaging and Biology’s 2025 Journal Impact Factor is 2.5, and its 5-year Impact Factor is 2.6.
2.5
Journal Impact Factor (2025)
2.6
5-year Impact Factor (2025)
19 days
Median time to first decision
Source: journal metrics on the Molecular Imaging and Biology homepage (Springer Nature), checked November 22, 2026. Impact Factor from Clarivate Journal Citation Reports.
Recent Molecular Imaging and Biology research worth reading
Published February to May 2026. Summaries describe what the authors report.
-
Magnetically Controlled Nanocarriers for Site-Specific Drug Delivery and Theranostics in Cancer Precision Medicine
The authors review magnetically controlled nanocarriers, mostly based on superparamagnetic iron oxide, that combine targeted drug delivery with real-time imaging in cancer, and discuss remaining barriers such as deep tissue targeting, biosafety, scalable synthesis and regulation.
Singh et al. · Molecular Imaging and Biology, published online March 16, 2026 · DOI 10.1007/s11307-026-02097-6
-
Recent Advances in the Development of CRISPR-Based Live-Cell Molecular Imaging and Sensing
The authors review CRISPR-based platforms for imaging DNA and RNA in living cells, sorting them into live-cell imaging, intracellular sensing and diagnostic biosensing, and weighing trade-offs such as sensitivity against how much each system disturbs the cell.
Hou et al. · Molecular Imaging and Biology, published online May 13, 2026 · DOI 10.1007/s11307-026-02110-y
-
Engineering Anti-MMP-9 Peptide-Modified Nanoparticles for Precision MRI Diagnosis of Endometriosis
The authors developed gadolinium-based nanoparticles carrying an anti-MMP-9 peptide and report that, within 48 h of injection, they accumulated significantly in endometriotic lesions on MRI and fluorescence imaging, suggesting a non-invasive way to detect the disease.
Zhang et al. · Molecular Imaging and Biology, published online February 27, 2026 · DOI 10.1007/s11307-026-02086-9
-
Comparison of [18F]FDG and [18F]PSMA-1007 PET/CT in the Evaluation of Muscle-Invasive Bladder Cancer: A Pilot Feasibility Study
In six patients with muscle-invasive bladder cancer, the authors report that [18F]PSMA-1007 PET/CT detected primary bladder lesions in 5 of 6 patients versus 3 of 6 with [18F]FDG, while both tracers showed comparable sensitivity for metastatic disease.
Avilez et al. · Molecular Imaging and Biology, published online March 23, 2026 · DOI 10.1007/s11307-026-02085-w
-
An Optimized Fast Track Protocol to Enhance the Image Quality of 18F-FDG PET Myocardial Viability Imaging in Diabetic CAD Patients: A Randomized Controlled Trial
In a randomized trial of 50 diabetic patients with coronary artery disease, the authors report that an optimized fast-track preparation protocol gave more interpretable 18F-FDG PET viability scans than the standard approach (92% vs 64%) and shorter preparation time.
Mandal et al. · Molecular Imaging and Biology, published online April 14, 2026 · DOI 10.1007/s11307-025-02074-5
Related journals
Questions about Molecular Imaging and Biology
How can I read Molecular Imaging and Biology articles without a subscription?
41% of Molecular Imaging and Biology articles published from January 1 to November 20, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read Molecular Imaging and Biology articles online for $59 a month or $499 a year after a free first month.
What is the abbreviation for Molecular Imaging and Biology?
Molecular Imaging and Biology’s NLM (PubMed) abbreviation is Mol Imaging Biol.
What is the ISSN of Molecular Imaging and Biology?
The print ISSN is 1536-1632 and the online ISSN is 1860-2002.
What is the impact factor of Molecular Imaging and Biology?
Molecular Imaging and Biology’s Journal Impact Factor is 2.5 (2025), and its 5-year Impact Factor is 2.6, according to Springer Nature’s published metrics.
Is Molecular Imaging and Biology open access?
Molecular Imaging and Biology is a hybrid journal: most articles are published under the subscription model, and authors can choose to publish open access. From January 1 to November 20, 2026, 29 of 71 Molecular Imaging and Biology articles (41%) carry a Creative Commons license, per Crossref.
Molecular Imaging and Biology articles on DeepDyve are licensed from Springer Nature. Journal facts as of 22 November 2026.
Start reading Molecular Imaging and Biology today
One month free, then less than $2 a day. Molecular Imaging and Biology, plus millions of articles from thousands of journals.





